Additional file 1: Tables S1 to S4. of The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

Young, Jim; Weis, Nina; Hofer, Harald; Irving, William; Weiland, Ola; Giostra, Emiliano; Pascasio, Juan; Castells, Lluis; Prieto, Martin; Postema, Roelien; Lefevre, Cinira; Evans, David; Bucher, Heiner; Calleja, Jose

doi:10.6084/m9.figshare.c.3660338_D1.v1

12879_2016_2106_MOESM1_ESM.doc (90.5 kB)

Additional file 1: Tables S1 to S4. of The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

journal contribution

posted on 2017-01-07, 05:00 authored by Jim Young, Nina Weis, Harald Hofer, William Irving, Ola Weiland, Emiliano Giostra, Juan Pascasio, Lluis Castells, Martin Prieto, Roelien Postema, Cinira Lefevre, David Evans, Heiner Bucher, Jose Calleja

This file consists of a title page, a table of contents, a brief introduction to hierarchical Bayesian modelling, references and four tables of results (one table per page). (DOC 90 kb)

Funding

Bristol-Myers Squibb

History

Usage metrics

Keywords

Daclatasvir Direct-acting antivirals Effectiveness Hepatitis C Sofosbuvir

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: Tables S1 to S4. of The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

Funding

Bristol-Myers Squibb

History

Usage metrics

Categories

Keywords

Licence

Exports